allo-hsct for cll in the era of novel agents
Published 4 years ago • 118 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:00
how do novel agents affect allogeneic transplantation in cll?
-
2:24
what is the role of allogeneic stem cell transplantation in cll in the light of novel drugs?
-
1:42
the role of allo transplantation in cll
-
3:03
all patients & allo-hsct
-
1:09
the role of allosct in lbcl in the era of car-t
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
6:59
reduced-intensity conditioning regimens in all patients undergoing allo-hsct
-
4:34
arthur's story: his cll diagnosis. challenges, treatments and future hope.
-
6:38
allogeneic stem cell transplant - know what to expect in hospital [video 1 of 2]
-
15:19
t cell development in the thymus
-
0:54
the role of allogeneic stem cell transplantation in cll
-
6:45
novel scoring system defines allo-hsct patients at high risk for cmv
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:16
αβ t-cell depleted allo-hsct for hematological malignancies
-
0:38
optimal time for allo-hsct in aml
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
2:12
mutation profile in cmml undergoing allo-hsct
-
3:40
cd4 t-cell reconstitution in allo-hsct settings
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:28
the future of cll treatment
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity